Search JIM
Advanced Search
Journal of Chinese Integrative Medicine ›› 2011, Vol. 9 ›› Issue (3): 246-251.doi: 10.3736/jcim20110304
• Methodology • Previous Articles Next Articles
Zhao-lan Liu1, Bao-quan Liu2, Lan-hua Li3, Jian-ping Liu1(
)
| [1] | Fisher RA . The design of experiments[M]. Edinburgh: Oliver and Boyd, 1935 |
| [2] | Tang DL. Fundamental of medical statistics[M]. Beijing: People's Medical Publishing House, 1989 |
| 汤旦林 . 医学统计学基础[M]. 北京: 人民卫生出版社, 1989 | |
| [3] | Friedman LM, Furberg CD, DeMets DL .Fundamentals of clinical trials(3rd ed)[M]. New York: Springer Science+Business Media, LLC, 1998 |
| [4] | Efron B . International Symposium on Hodgkin's Disease. Session 6. Survival data and prognosis. Invited discussion: Forcing a sequential experiment to be balanced[J]. Natl Cancer Inst Monogr, 1973,36:571-572 |
| [5] |
Wei LJ . An application of an urn model to the design of sequential controlled clinical trials[J]. J Am Stat Assoc, 1978,73(363):559-563
doi: 10.1080/01621459.1978.10480054 |
| [6] |
Pocock SJ, Simon R . Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial[J]. Biometrics, 1975,31(1):103-115
doi: 10.2307/2529712 |
| [7] |
Freedman LS, White SJ . On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial[J]. Biometrics, 1976,32(3):691-694
doi: 10.2307/2529759 |
| [8] |
Taves DR . Optimum Optimum biased-coin designs for sequential treatment allocation with covariate information by A. C. Atkinson, Statistics in Medicine 1999; 18:1741-1752[J]. Stat Med, 2001,20(5):813-818
doi: 10.1002/(ISSN)1097-0258 |
| [9] |
Taves DR . Minimization: a new method of assigning patients to treatment and control groups[J]. Clin Pharmacol Ther, 1974,15(5):443-453
doi: 10.1002/cpt1974155443 pmid: 4597226 |
| [10] |
Therneau TM . How many stratification factors are "too many" to use in a randomization plan[J]. Control Clin Trials, 1993,14(2):98-108
doi: 10.1016/0197-2456(93)90013-4 pmid: 8500309 |
| [11] | ICH Expert Working Group . International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised tripartite guidelines. E9: statistical principles for clinical trials. 1998. |
| [12] | Moher D, Hopewell S, Schulz KF, Montori V, Gtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG .CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials(Chinese version)[J]. J Chin Integr Med, 2010,8(8):701-741 |
| Moher D, Hopewell S, Schulz KF, Montori V, Gtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG.CONSORT 2010说明与详述:报告平行对照随机临床试验指南的更新[J]. 中西医结合学报, 2010,8(8):701-741 | |
| [13] |
Scott NW, McPherson GC, Ramsay CR, Campbell MK .The method of minimization for allocation to clinical trials: a review[J]. Control Clin Trials, 2002,23(6):662-674
doi: 10.1016/S0197-2456(02)00242-8 |
| [14] | Wen TC, Yan SY, Liu BY, He LY, Su TS . Application of minimized and randomized algorithm in research of hydrocephalus improved by traditional Chinese medicine[J]. Zhongguo Shu Zi Yi Xue, 2008,3(10):17-18 |
| 文天才, 闫世艳, 刘保延, 何丽云, 苏同生 . 最小化随机算法在中医药改善脑积水临床研究中的应用[J]. 中国数字医学, 2008,3(10):17-18 |
| [1] | Bellavite Paolo, Marzotto Marta, Bonafini Clara. Arnica montana experimental studies: Confounders and biases?. Journal of Integrative Medicine, 2018, 16(2): 72-76. |
| [2] | Salvatore Chirumbolo, Geir Bjørklund. Homeopathic potencies of Arnica montana L. change gene expression in a Tamm-Horsfall protein-1 cell line in vitro model: The role of ethanol as a possible confounder and statistical bias. Journal of Integrative Medicine, 2017, 15(4): 255-264. |
| [3] | Arthur Yin Fan. The methodology flaws in Hinman’s acupuncture clinical trial, Part II: Zelen design and effectiveness dilutions. Journal of Integrative Medicine, 2015, 13(3): 136-139. |
| [4] | Arthur Yin Fan. The methodology flaws in Hinman’s acupuncture clinical trial, Part I: Design and results interpretation. Journal of Integrative Medicine, 2015, 13(2): 65-68. |
| [5] | Liang-ping Hu, Xiao-lei Bao, Chen-long Lv. Two-factor designs unable to examine the interactions (Part 2). Journal of Chinese Integrative Medicine, 2012, 10(9): 966-969. |
| [6] | Ming T. Tan , Jian-ping Liu , Lixing Lao. Adequate application of quantitative and qualitative statistic analytic methods in acupuncture clinical trials. Journal of Chinese Integrative Medicine, 2012, 10(8): 847-852. |
| [7] | Liang-ping Hu, Xiao-lei Bao, Chen-yi Guo . Two-factor designs unable to examine the interactions (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(8): 853-857. |
| [8] | Liang-ping Hu , Xiao-lei Bao, Chen-long Lü . How to choose an appropriate experimental design type (Part 2). Journal of Chinese Integrative Medicine, 2012, 10(7): 738-742. |
| [9] | Liang-ping Hu, Xiao-lei Bao. How to choose an appropriate experimental design type (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(6): 615-618. |
| [10] | Liang-ping Hu, Xiao-lei Bao, Qi Wang . The balance principle in scientific research. Journal of Chinese Integrative Medicine, 2012, 10(5): 504-507. |
| [11] | Liang-ping Hu, Xiao-lei Bao, Xue Guan . Estimation of sample size and testing power (Part 7). Journal of Chinese Integrative Medicine, 2012, 10(4): 380-383. |
| [12] | Hu Liang-ping, Bao Xiao-lei, Guan Xue, Zhou Shi-guo. Estimation of sample size and testing power (Part 6). Journal of Chinese Integrative Medicine, 2012, 10(3): 298-302. |
| [13] | Hu Liang-ping, Bao Xiao-lei, Guan Xue, Zhou Shi-guo. Estimation of sample size and testing power (Part 5). Journal of Chinese Integrative Medicine, 2012, 10(2): 154-159. |
| [14] | Xiao-lei Bao, Liang-ping Hu. Multifactor designs able to examine the interactions. Journal of Chinese Integrative Medicine, 2012, 10(12): 1371-1374. |
| [15] | Liang-ping Hu, Xiao-lei Bao. Three-factor designs unable to examine the interactions (Part 2). Journal of Chinese Integrative Medicine, 2012, 10(11): 1229-1232. |
|
沪公网安备31010602003416号 沪ICP备18017633号-3
